CRISPR-Cas9 approach confirms Calcineurin-responsive zinc finger 1 (Crz1) transcription factor as a promising therapeutic target in echinocandin-resistant Candida glabrata.
PLoS One
; 17(3): e0265777, 2022.
Article
in En
| MEDLINE
| ID: mdl-35303047
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Candida glabrata
/
Echinocandins
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
PLoS One
Journal subject:
CIENCIA
/
MEDICINA
Year:
2022
Document type:
Article
Affiliation country:
Colombia